It shaves a few days off the recovery time, but I wouldn't call it a game-changer.
Still waiting on the HCQ results, though. That, and the famotidine study, which is an intriguing one. Cheaper drugs like those have more potential to help more people than the more expensive last-resort drugs like remdesivir.